# Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence

> **NCT03104517** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Cook MyoSite** · enrollment: 96 (estimated)

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **BIOLOGICAL:** AMDC-USR (iltamiocel)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03104517
- **Lead sponsor:** Cook MyoSite
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-04-23
- **Primary completion:** 2026-09
- **Final completion:** 2027-09
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03104517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03104517, "Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03104517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*